Increased secretion of tissue inhibitors of metalloproteinases 1 and 2 from the aortas of cholesterol fed rabbits partially counterbalances increased metalloproteinase activity

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 19, Issue 7, 1999, Pages 1700-1707

  Zaltsman, A B ^a,b   George, S J ^a   Newby, A C ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b BRISTOL ROYAL INFIRMARY   (United Kingdom)

Author keywords

Atherosclerosis; Cholesterol; Tissue inhibitor of metalloproteinases

Indexed keywords

TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ANIMAL EXPERIMENT; AORTA ATHEROSCLEROSIS; ARTICLE; ATHEROGENESIS; ATHEROSCLEROTIC PLAQUE; CHOLESTEROL BLOOD LEVEL; ENZYME ACTIVITY; ENZYME RELEASE; EXTRACELLULAR MATRIX; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; RABBIT; THORACIC AORTA; ZYMOGRAPHY;

EID: 0033067605     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.19.7.1700     Document Type: Article

References (37)

1. Ross R, Wight TN, Strandness E, Thiele E. Human atherosclerosis, 1. Cell constituents and characteristics of advanced lesions of the superficial femoral artery. Am J Pathol. 1984;114:79-93.
2. Lendon CL, Davies MJ, Born GVR, Richardson PD. Atherosclerotic plaque caps are locally weakened when macrophage density is increased. Atherosclerosis. 1991;87:87-91.
3. Galis ZS, Sukhova GK, Lark MW, Libby P. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest. 1994;94: 2493-2503.
4. Henney AM, Wakely PR, Davies MJ, Foster K, Hembry R, Murphy G, Humphries S. Localization of stromelysin gene expression in atherosclerotic plaques by in situ hybridization. Proc Natl Acad Sci U S A. 1991;88:8154-8158.
5. Galis ZS, Sukhova GK, Kranzhöfer R, Clark S, Libby P. Macrophage foam cells from experimental atheroma constitutively express matrix-degrading proteases. Proc Natl Acad Sci U S A. 1995;92:402-406.
6. Lee RT, Schoen FJ, Loree HM, Lark MW, Libby P. Circumferential stress and matrix metalloproteinase 1 in human atherosclerosis: implications for plaque rupture. Arterioscler Thromb Vase Biol. 1996;16: 1070-1073.
7. Zaltsman AB, Newby AC. Increased secretion of gelatinases A and B from the aortas of cholesterol fed rabbits: relationship to lesion severity. Atherosclerosis. 1997;130:61-70.
8. Birkedal-Hansen H, Moore WGI, Bodden MK, Windsor LJ, Birkedal-Hansen B, De Carlo A, Engler JA. Matrix metalloproteinases: a review. Crit Rev Oral Biol Med. 1993;4:197-250.
9. Cawston TE. Metalloproteinase inhibitors and the prevention of connective-tissue breakdown. Pharmacol Ther. 1996;70:163-182.
10. Brophy CM, Marks WH, Reilly JM, Tilson MD. Decreased tissue inhibitor of metalloproteinases in abdominal aortic aneurysm tissue: a preliminary report. J Surg Res. 1991;50:653-657.
11. Galis ZS, Muszynski M, Sukhova GK, Simon-Morissey E, Unemori E, Lark MW, Amento E, Libby P. Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of extracellular enzymes required for extracellular matrix degradation. Circ Res. 1994;75:181-189.
12. Nikkari ST, Geary RL, Hatsukami T, Ferguson M, Forough R, Allpers CE, Clowes AW. Expression of collagen, interstitial collagenase, and tissue inhibitor of metalloproteinase-1 in restenosis after carotid endarterectomy. Am J Pathol. 1996;148:777-783.
13. Fabunmi RP, Baker AH, Murray EJ, Booth RFG, Newby AC. Divergent regulation by growth factors and cytokines of 95-kDa and 72-kDa gelatinases and tissue inhibitors of metalloproteinases-1, -2 and -3 in rabbit aortic smooth muscle cells. Biochem J. 1996;315:335-342.
14. Leco KJ, Khokha R, Pavloff N, Hawkes SP, Edwards DR. Tissue inhibitor of metalloproteinases-3 (TIMP-3) is an extracellular matrix associated protein with a distinctive pattern of expression in mouse cells and tissues. J Biol Chem. 1994;269:9352-9360.
15. O'Connell JP, Willenbrock F, Docherty AJP, Eaton D, Murphy G. Analysis of the role of the COOH-terminal domain in the activation, proteolytic activity and tissue inhibitor of metalloproteinase interactions of gelatinase B. J Biol Chem. 1994;269:14961-14973.
16. Murphy G, Willenbrock F, Ward RV, Cockett MI, Eaton D, Docherty AJP. The C-terminal domain of 72 kDa gelatinase A is not required for catalysis but is essential for membrane activation and modulates interactions with tissue inhibitors of metalloproteinases. Biochem J. 1992;283: 637-641.
17. Strongin AY, Collier I, Bannikov BL, Grant GA, Goldberg GI. Mechanism of cell surface activation of 72 kDa type IV collagenase. J Biol Chem. 1995;000:00000-00000.
18. Wang H, Moore S, Alavi MZ. Synthesis of tissue inhibitor of metalloproleinase-1 (TIMP-1) in rabbit aortic neointima after selective deendothelialisation. Atherosclerosis. 1996;126:95-104.
19. Hasenstab D, Forough R, Clowes AW. Plasminogen activator inhibitor type 1 and tissue inhibitor of metalloproteinases-2 increase after arterial injury in rats. Circ Res. 1997;80:490-496.
20. Webb KE, Henney AM, Anglin S, Humphries SE, McEwan JR. Expression of matrix metalloproteinases and their inhibitor TIMP-1 in the rat carotid artery after balloon injury. Arterioscler Thromb Vasc Biol. 1997;17:1837-1844.
21. Galis ZS, Sukhova GK, Libby P. Microscopic localization of active proteases by in situ zymography: detection of matrix metalloproteinase activity in vascular tissue. FASEB J. 1995;9:974-980.
22. McMurray H, Parrott DP, Bowyer DE. A standardised method of culturing aortic explants, suitable for the study of factors affecting the phenotypic modulation, migration and proliferation of aortic smooth muscle cells. Atherosclerosis. 1991;86:227-237.
23. Southgate KM, Newby AC. Serum-induced proliferation of rabbit aortic smooth muscle cells from the contractile state is inhibited by 8-Br-cAMP but not 8-Br-cGMP. Atherosclerosis. 1990;82:113-123.
24. Ward RV, Hembry RM, Reynolds JJ, Murphy G. The purification of tissue inhibitor of metalloproteinases-2 from its 72 kDa progelatinase complex. Biochem J. 1991;278:179-187.
25. Southgate KM, Davies M, Booth RFG, Newby AC. Involvement of extracellular-matrix-degrading metalloproteinases in rabbit aortic smooth muscle cell proliferation. Biochem J. 1992;288:93-99.
26. Murphy G, Nguyen Q, Cockett MI, Atkinson SJ, Allan JA, Knight CG. Assessment of the role of the fibronectin like domain of gelatinase A by analysis of a deletion mutant. J Biol Chem. 1994;269:6632-6636.
27. Anitschkow N, Chalatow S. Über experimentelle cholesterinsteatose und ihre bendeutung fur die enstehung einiger: pathologischer prozess. Allg Pathol Anat. 1913;24:1-13.
28. Knox JB, Sukhova GK, Whittemore AD, Libby P. Evidence for altered balance between matrix metalloproteinases and their inhibitors in human aortic diseases. Circulation. 1997;95:205-212.
29. Keen RR, Nolan KD, Cipollone M, Scott E, Shively VP, Yao JST, Pearce WH. Interleukin-1 beta induces differential gene-expression in aortic smooth muscle cells. J Vasc Surg. 1994;20:774-786.
30. Hembry RM, Murphy G, Reynolds JJ. Immunolocalization of tissue inhibitor of metalloproteinases (TIMP) in human cells: characterization and use of a specific antiserum. J Cell Sci. 1985;73:105-119.
31. Kranzhöfer A, Baker AH, George SJ, Newby AC. Expression of tissue inhibitor of metalloproteinases-1, -2 and -3 during neointima formation in organ cultures of human saphertous vein. Arterioscler Thromb Vasc Biol. 1999;19:255-265.
32. Nguyen Q, Willenbrock F, Cockett MI, Oshea M, Docherty AJP, Murphy G. Different domain interactions are involved in the binding of tissue inhibitors of metalloproteinases to stromelysin-1 and gelatinase-A. Biochemistry. 1994;338:2089-2095.
33. Newby AC, Zaltsman AB. Fibrous cap formation or destruction: the critical importance of vascular smooth muscle cell proliferation, migration and matrix formation. Cardiovasc Res. 1999;41:345-360.
34. Dollery CM, McEwan JR, Henney AM. Matrix metalloproteinases and cardiovascular disease. Circ Res. 1995;77:863-868.
35. Lee RT, Libby P. The unstable atheroma. Arterioscler Thromb Vasc Biol. 1997;17:1859-1867.
36. Cawston TE. Metalloproteinase inhibitors and the prevention of connective tissue breakdown. Pharmacol Ther. 1996;70:163-182.
37. George SJ, Johnson J, Angelini GD, Newby AC, Baker AH. Adenovirus mediated gene transfer of the human TIMP-1 gene inhibits smooth muscle cell migration and neointima formation in human saphenous vein. Hum Gene Ther. 1998;9:867-877.